Jianhua Zhang

44PUBLICATIONS
502CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsCancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Nov 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.

Melinda Soeung, Xinmiao Yan, Ciro Zanca

|Jul 02, 2025
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation.

Hidetaka Uryu, Koichi Saeki, Hiroshi Haeno

|Feb 21, 2025
Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial.

Sangeeta Goswami, Jianjun Gao, Sreyashi Basu

|Feb 19, 2025
The mutational landscape and functional effects of noncoding ultraconserved elements in human cancers.

Recep Bayraktar, Yitao Tang, Mihnea P Dragomir

|Nov 28, 2024
Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinoma.

Sangeeta Goswami, Jianjun Gao, Sreyashi Basu

|May 27, 2024
The evolution of lung adenocarcinoma precursors is associated with chromosomal instability and transition from innate to adaptive immune response/evasion.

Xin Hu, Bo Zhu, Natalie Vokes

Pageof 8

Frequent Collaborators

33 joint publications

P Andrew Futreal

13 joint publications

Linghua Wang

8 joint publications

Alexandre Reuben

8 joint publications

Koichi Takahashi